Senior Medical Science Liaison

PTC Therapeutics

Remote, Germany

Job Description:

The Senior Medical Science Liaison (Sr. MSL) is a field based position of Medical Affairs that supports and represents PTC and its products with, and to, key opinion leaders (KOLs), clinicians, academic institutions, and professional organizations.

Based in Germany, the Sr. MSL is a key part of both the PTC Germany team and the broader Central Europe (CE) team. As a clinical and medical expert on the company’s products, he/she builds long-term relationships and establishes rapport with clinicians in hospitals, clinics, and academic centres through highly scientific product and disease state discussions that support or expand current therapeutic concepts and ensures safe and effective utilization of products.

The Senior Medical Science Liaison provides leadership in multiple therapeutic areas including pipeline products across a broader geographical scope. He/she reports directly to the Senior Medical Director CE.

This role may have direct team management or coaching responsibilities in the future and is expected to contribute to PTC’s Medical Affairs work and projects internationally.

Responsibilities of the Role Include:

Attends national and regional medical meetings and symposia as a representative of PTC and engages in discussions with attendees as appropriate; attends scientific sessions and poster presentations, gathers information, and summarizes findings; as possible, and when appropriate, cultivates professional relationships from these contacts;
Delivers, and may develop/design, fair-balanced and objective clinical and scientific presentations to healthcare professionals (HCPs), payors, patient organizations in response to unsolicited requests for information on the use of company products;
Identifies and trains speakers for advisory boards, symposia, and educational programs with regulatory approved materials, slides sets, abstracts, posters, etc.;
Identifies, organizes and carries out regional medical initiatives e.g advisory board meetings, stand-alone meetings, congress symposia, poster presentations as needed;
Chair Advisory Boards and/or round tables and communicate efficiently the relevant insights to the CE leadership team;
Provides input to CE leadership regarding alternative therapies, business development opportunities/risks, and client feedback;
Develops and delivers scientific content to educate colleagues from other functions such as Commercial & Marketing;
Support Market Access team in providing and developing medical content including support in the pharmacoeconomic assessments;
Creation, review and approval of field based cross functional communication materials and activities;
Establishes, manages and maintains successful relations with relevant health authorities, including but not limited to: KOLs, HCPs, academic institutions, payors, patient organizations, etc.;
Facilitates the accurate and timely submission of applications for unrestricted educational grants or research initiatives and Investigator Sponsored Study (ISS) requests, per company policy and acts as the primary PTC contact in such activities;
Maintains a thorough awareness of medical/clinical, regulator, compliance and quality issues and processes as they apply to the PTC therapeutic areas and adheres to, and supports, the standards established by the company;
Maintains competitor information relevant to company’s therapeutic areas, goals/objectives, project activities and /product team priorities and stays current on therapeutic advances and competing therapies or products; analyzes and applies relevant intelligence findings and communicates and presents insightful data/impact in an efficient format to appropriate internal stake holders;
Works closely alongslide the Sr. Medical Director CE to feed into medical strategy and tactics for Germany and the whole CE cluster;
Due to his/her experience the incumbent acts as a natural mentor and guide to the other MSLs in the region.

Requirements for the Role Include:

Experience supporting an orphan, rare disease and/or specialized drug(s);
Preferred Advanced degree (e.g., Masters, MPH, PharmD, M.D. or Ph.D.) in a scientific discipline and a minimum of 8 years progressively responsible, relevant experience in a pharmaceutical, biotechnology or related environment with a minimum of 4 years’ experience as an MSL or equivalent;
Experience working in rare- and/or ultra-rare conditions that require extensive coordination with patient access services;
Experience in neurology, metabolics, neuropediatrics is a plus;
Experience working in small biotechnology companies is a plus;
In-depth, hands-on experience working with KOLs, clinicians, HCPs, payors and/or academic institutions establishing/maintaining relationships and scientific/medical credibility;
Demonstrated success in interpreting scientific data and presenting research information to scientists and HCPs;
Excellent understanding of the pharmaceutical delivery process;
Ability to influence without direct authority;
Proficiency with Microsoft Office;
Excellent verbal and written communication and skills, including scientific/technical writing and presentations including the ability to communicate complex technical information clearly;
Ability to work independently and collaboratively, as required, in a fast-paced, matrixed, team environment consisting of internal and external team members;
Analytical thinker with excellent problem solving skills and the ability to adapt to changing priorities and deadlines;
Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects;
Must possess a valid driver’s license. Must be able to travel on a daily basis to/from customer accounts and drive and/or fly long distances (distances will vary based upon the size of assigned territory);
This position requires overnight travel, the amount of which will vary based upon the assigned territory. In addition to travel within the territory, overnight and/or weekend travel outside of the assigned territory is required. It is estimated that travel requirements will be around 50-60%, but may fluctuate up to 80%.